Emei Shan Tourism Company Limited operates in the Botanical and zoological gardens sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Emei Shan Tourism Company Limited with three other
miscellaneous service companies in Asia:
Shin Nippon Biomedical Laboratories Ltd
sales of 16.60 billion Japanese Yen [US$153.56 million]
of which 84%
was Pre-Clinical Business),
WITH us Corporation
(16.24 billion Japanese Yen [US$150.23 million]
GiG Works Inc
based in Japan
(16.05 billion Japanese Yen [US$148.49 million]
Emei Shan Tourism Company Limited reported sales of 1.07 billion Chinese Renmimbi (US$151.43 million)
December of 2018.
decrease of 0.6%
versus 2017, when the company's sales were 1.08 billion Chinese Renmimbi.
Contributing to the drop in overall sales was the 11.4% decline
in Other Operation, from 84.56 million Chinese Renmimbi to 74.93 million Chinese Renmimbi.
There were also decreases in sales in
Hotel (down 11.1% to 186.72 million Chinese Renmimbi)
However, these declines were partially offset by the increase in sales of
Tourism (up 3.3% to 810.70 million Chinese Renmimbi)